Pharmaxis Announces Bronchitol Distributor for Brazil
Release Date: 10/04/2013 12:00am
Pharmaceutical company Pharmaxis (ASX:PXS) is pleased to announce that it has appointed United Medical Ltda as exclusive distributor and sales representative for Bronchitol® in Brazil.
Under the terms of the agreement United Medical has responsibility for sales and marketing, pricing, warehousing, distribution and patient support. United will shortly file a marketing approval application with the Brazilian regulatory agency (ANVISA) based on Bronchitol’s Australian approval, a process which is expected to take up to 18 months. Pharmaxis will receive milestone payments ahead of Bronchitol’s approval in Brazil.
United Medical is a well-established healthcare company based in São Paulo. It partners with leading global pharmaceutical companies and its sales team has worked closely with the cystic fibrosis medical community in Brazil since 1999.
Categories: News and Media